|
J Biol Chem, Vol. 274, Issue 47, 33714-33722, November 19, 1999
A Novel in Vitro Replication System for Dengue
Virus
INITIATION OF RNA SYNTHESIS AT THE 3'-END OF EXOGENOUS VIRAL RNA
TEMPLATES REQUIRES 5'- AND 3'-TERMINAL COMPLEMENTARY SEQUENCE
MOTIFS OF THE VIRAL RNA*
Shihyun
You and
R.
Padmanabhan
From the Department of Biochemistry and Molecular Biology,
University of Kansas Medical Center,
Kansas City, Kansas 66160-7421
 |
ABSTRACT |
Positive strand viral replicases are
membrane-bound complexes of viral and host proteins. The mechanism of
viral replication and the role of host proteins are not well
understood. To understand this mechanism, a viral replicase assay that
utilizes extracts from dengue virus-infected mosquito (C6/36) cells and
exogenous viral RNA templates is reported in this study. The 5'- and
3'-terminal regions (TR) of the template RNAs contain the conserved
elements including the complementary (cyclization) motifs and stem-loop structures. RNA synthesis in vitro requires both 5'- and
3'-TR present in the same template molecule or when the 5'-TR RNA was added in trans to the 3'-untranslated region (UTR) RNA.
However, the 3'-UTR RNA alone is not active. RNA synthesis occurs by
elongation of the 3'-end of the template RNA to yield predominantly a
double-stranded hairpin-like RNA product, twice the size of the
template RNA. These results suggest that an interaction between 5'- and
3'-TR of the viral RNA that modulates the 3'-UTR RNA structure is
required for RNA synthesis by the viral replicase. The complementary
cyclization motifs of the viral genome also seem to play an
important role in this interaction.
 |
INTRODUCTION |
The mosquito-borne dengue viruses, members of positive strand RNA
viruses of Flavivirus family, are human pathogens that cause dengue
fever, dengue hemorrhagic fever/dengue shock syndrome (for a review see
Refs. 1 and 2). It is currently estimated that about 40% of the world
population is at risk and about 5% of one million dengue hemorrhagic
fever cases per year are fatal (3). Dengue virus type 2 (DEN2), the
most prevalent of the four serotypes, contains a single-stranded RNA
genome of positive polarity that encodes a single polyprotein precursor
(3391 amino acid residues for DEN2, New Guinea C-strain) (4) arranged
in the order, C-prM-E-NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5. The precursor
polyprotein is processed into three structural proteins of the virion,
C, prM, and E, by the host signal peptidase associated with the
endoplasmic reticulum (5-7) and at least seven nonstructural proteins,
NS1 to NS5, which are expressed in the infected cells (for a review see
Ref. 8).
The processing of the nonstructural region of the polyprotein precursor
is catalyzed by the two-component, viral serine protease, NS2B/NS3,
first identified based on conserved catalytic triad of trypsine-like
serine proteases (9, 10). The serine protease domain of NS3, present
within the N-terminal 180 amino acid residues, requires NS2B for
activity (11-18). The crystal structure of the NS3 protease domain has
recently been reported (19). The C-terminal region of the NS3 protease
domain contains conserved motifs found in the NTP-binding proteins and
DEXH family of RNA helicases (20-22). The nucleoside triphosphatase
and RNA helicase activities of DEN2 NS3 have recently been demonstrated
by expression and purification of recombinant NS3 in Escherichia
coli (23). The RNA helicase activity is thought to be involved in
unwinding of a double-stranded RNA replicative intermediate formed
during replication of the flavivirus genome (8, 24). NS5, the largest
of the flaviviral proteins, contains conserved motifs found in many
viral RNA-dependent RNA polymerases
(RdRP)1 (25, 26), implicating
a role of NS5 in viral replication.
Template-dependent and template-specific in
vitro replication systems have been developed to study mechanisms
of some plant and a few eukaryotic positive strand RNA viruses. These
studies have revealed that viral replicases function as membrane-bound complexes of both viral and cellular proteins and viral RNA (Refs. 27-35 and for a review see Ref. 36). However, the mechanism of initiation of viral RNA synthesis as well as RNA genome replication in
general and the role of host proteins in this process remain unclear for positive strand RNA viruses.
In flavivirus-infected cells, three RNA species have been detected: a
genomic RNA of 40-44 S; a double-stranded, RNase-resistant, replicative form of 20-22 S; and a partially RNase-sensitive, replicative intermediate of 20-28 S RNA (37-40). The in
vitro RdRP assays that have been developed to study flavivirus
replication utilize membrane-bound complexes isolated from the infected
cell lysates (37-40). These studies have examined incorporation of
radiolabeled nucleotides into the three RNA species on endogenous viral
RNA templates. In these replication complexes, the endogenous
replicative intermediates present in the infected cell extracts were
shown to form a double-stranded replicative form. The replicative form produced endogenously from replicative intermediate or added
exogenously gave rise to a 44 S genome-size RNA species, suggesting
that initiation of (+)-strand RNA synthesis occurred in these in
vitro assays (39, 40).
To study the mechanism of viral replication in molecular detail, it is
crucial to develop an in vitro RdRP assay that can utilize
exogenous RNA templates containing essential regulatory elements of the
viral genome involved in viral replication. For initiation of ( )- and
(+)-strand RNA synthesis, conserved RNA sequences with intrinsic
stem-loop structures from the 3' and 5' regions of many viral genomes
are thought to play an important role in RNA replication (41-55). In
flavivirus genomes, such conserved elements have been noted previously;
their functions in replication remain to be established. For example,
the 3'-terminal 96 nucleotides of the mosquito-borne flaviviruses
within the 3'-UTR form a conserved and stable stem-loop structure,
although the primary sequence is not conserved (for a review see Ref.
8). Formation of such a stable secondary structure within the
3'-terminal 373 nt of the 3'-UTR was shown to exist in solution (56). A
potential secondary structure with a lesser predicted stability near
the 5' termini of several flavivirus RNAs including DEN2 was reported (57). There are also two short conserved sequences (CS1 and CS2) in
3'-UTR shared by all mosquito-borne flaviviruses; CS1, 26 nucleotides
in length, is located 5' to the stem-loop structure of the 3'-UTR
(3'-CS1). A portion of the 3'-CS1 is complementary to a conserved
element is located within the N-terminal coding region of the capsid
protein, C, in the 5'-TR of the viral genome (5'-CS). It has been
proposed that these complementary sequences might play a role in
cyclization of the viral genome (Ref. 58 and for a review see Ref. 8).
However, cyclization of any of the flavivirus genome has not been
observed to date. Thus the role of cyclization motifs in genome
replication is unknown at present.
In this study, we report the development of the first in
vitro RdRP assay that utilizes cell-free extracts of DEN2-infected mosquito (C6/36) cells and exogenous subgenomic RNA templates containing 5'- and/or 3'-terminal regions of the viral genome. The
results indicate that there is an interaction between 5'- and
3'-terminal regions of the viral RNA that is required for RNA synthesis
in vitro. This interaction is modulated by the complementary cyclization motifs. RNA synthesis occurs by the 3'-end elongation of
the template RNA to yield a predominantly double-stranded RNA hairpin
with a limited single-stranded loop region. The kinetics of the
formation of the RNA hairpin product indicates that the template RNA is
first modified yielding a RNase A-sensitive intermediate that is then
converted to the hairpin product twice the size of the template RNA.
This in vitro RdRP assay will be useful to study the
sequence and protein requirements for RNA synthesis in
vitro.
 |
EXPERIMENTAL PROCEDURES |
Preparation of DEN2 Viral Replicase Complex from the Infected
Mosquito (C6/36) Cells
Dengue virus type 2 (New Guinea Strain C) was propagated as
described (59, 60). To obtain the DEN2 viral replication complex, C6/36
cells were infected with DEN2 virus (multiplicity of infection = 5) in
T-150 cm2 flasks for 36 h at 28 °C. Uninfected
C6/36 cells were used as controls. Cells were harvested by
centrifugation at 800 × g for 10 min, and the cell
pellet was resuspended in 0.5 ml of TNMg buffer (10 mM
Tris-HCl, pH 8.0, 10 mM sodium acetate, 1.5 mM
MgCl2) per T-150 cm2 flask. After passing the
cell suspension 20 times through a syringe (one ml capacity), fitted
with a 27-guage needle, the cell lysates were centrifuged at 800 × g for 10 min at 4 °C to fractionate the cytoplasmic
and nuclear fractions as described (39). The protein concentrations of
the cytoplasmic extracts were determined as described (61), and the
extracts were stored in aliquots at 70 °C until used.
Western Blot Analysis
An aliquot of the cytoplasmic extract was mixed with an equal
volume of a 2× sample loading buffer (62.5 mM Tris-HCl, pH
6.8, 2% SDS, 0.7 M -mercaptoethanol, 10% glycerol,
0.05% bromphenol blue). Proteins were separated by SDS-PAGE (10%) and
transferred electrophoretically to a polyvinylidene difluoride
membrane. The membrane was treated with nonfat dry milk (5%) for
2 h in Tris-buffered saline containing 0.1% Tween-20, pH 7.5, and
then incubated overnight with polyclonal rabbit anti-NS3 or anti-NS5
antibodies (1:2000). The membranes were washed three times for 20 min
each with this buffer and incubated with horseradish peroxidase-labeled
goat anti-rabbit antibody (1:20000) for 2 h at room temperature.
Chemiluminescence detection of the immunoreactive bands were performed
as described by the manufacturer (ECL system; Amersham Pharmacia Biotech).
Plasmid Constructs
3'-UTR373nt/wtCYC Plasmid--
The p190-24 plasmid
contains the 3'-terminal 373 nt from the DEN2 cDNA and 26 nt from
the pGEM7Zf+ vector (TCAAGCTATGCATCCAACGCGTTGGG) under the
control of SP6 promoter (56). When this plasmid is linearized with
XbaI, the cDNA of ( )-strand polarity was extended by 4 additional nucleotides of the XbaI-5' overhang. The RNA
synthesized from this template strand would include the 4 additional
nucleotides complementary to this overhang at its 3'-end. To generate
3'-UTR373nt RNA, which contains the wild type cyclization
sequence but without these 4 additional nucleotides, two approaches
were followed. Firstly, a PCR approach was followed using the two
oligonucleotide primers: the upstream 5'-primer (A),
5'-TGACCATGATTACGCCAAGCTATTTAGGTG-3' anneals a region
upstream of the SP6 promoter and a part of the promoter (underlined);
the downstream 3' primer (B), 5'-AGAACCTGTTGATTCAACAGCACC-3' is
complementary to the 3'-end of the viral genome. The PCR fragment was
purified and used for in vitro transcription (see below). In
the second approach, the XbaI-linearized p190-24 plasmid (10 µg in each reaction) was treated with increasing amounts of S1 nuclease (0, 3, 10, 30, 75, and 150 units) in 100 µl of reaction mixtures containing 50 mM sodium acetate, pH 4.5, 28 mM NaCl, and 4.5 mM ZnSO4 at room
temperature for 30', extracted with phenol, and precipitated with
ethanol. The S1 nuclease-treated plasmids were used for the in
vitro transcription catalyzed by SP6 RNA polymerase. To ensure
that the S1 nuclease precisely removed the XbaI overhang,
the blunt ends were ligated by T4 DNA ligase and cloned. DNA sequencing
was carried out using an automated DNA sequencer (Biotech Facility,
University of Kansas Medical Center).
cDNA Constructs Encoding Subgenomic RNA Containing the 5'- and
3'-Terminal Regions of DEN2 Genome--
A 230-nt DNA fragment from the
5'-terminal region that includes the 5'-UTR (96 nt), and the 5'-CS1 was
generated by PCR using pMK4 as a template and the upstream primer (C),
5'-CGGAATTCGGATCGATCCCCCCTAATAC-3' (containing the T7
promoter), and the downstream primer (D)
5'-CAGTTCCTGAGGTCCTCGTCCCTGCAG-3' (complementary to
217-233 nt of the viral genome, which includes the 5'-CS1 element).
The primers, C and D, contain the EcoRI and Bsu36I sites (underlined), respectively. The PCR product was
digested with EcoRI and Bsu36I and purified using
a Qiagen cartridge. The 3'-terminal fragment (800 nt) that includes the
3'-UTR was derived from the plasmid clone pGEM-PCR1.3 (4) by digestion
with Bsu36I (nt position 9885) and XbaI (nt
position 10723). The pSP64 vector plasmid was digested at the multiple
cloning site with EcoRI and XbaI. A
three-fragment ligation and cloning yielded pSY-1 plasmid containing
DEN2 cDNA sequences under the control of T7 promoter. To construct
a plasmid encoding a shorter subgenomic RNA, the pSY-1 plasmid was
partially digested with XmnI, followed by digestion with
Bsu36I. The overhang from the Bsu36I-cut plasmid
was blunt-ended by treatment with E. coli Klenow DNA
polymerase fragment and was cloned to yield the pSY-2 plasmid (720 nt)
in which 348 nt from the pSY-1 was deleted but retaining all of 3'-UTR
region. The pSY-1 and pSY-2 plasmids were used to produce the
subgenomic RNAs of 1.0 kilobase and 720 nt, respectively, by in
vitro transcription (Fig. 1).
5'-TR/mutCYC and 3'-UTR373nt/mutCYC Plasmids--
To
construct a PCR fragment of 5'-TR/mutCYC (which contains substitution
mutations within the cyclization sequence), a PCR-based mutagenesis
protocol was followed. Two PCR products were generated with overlapping
sequences using two sets of primers. PCR1 was obtained using the
5'-primer (E), containing the EcoRI site,
5'-AGCTATGACCATGATTACGAATTC-3' that corresponds to the upstream region
of the T7 promoter in the pSP64 vector and the 3'-primer (F),
5'-TTTCACAGAGAGAGAAGGCGTATTTCTCGCCTTT-3'. PCR2 was
produced using the 5' primer (G),
5'-GCCTTCTCTCTCTGTGAAACGCGAGAGAAACCG-3', and the 3' primer
(H), 5'-TGAGGTCCTCGTCCTG-3'. The underlined complementary sequences in F and G primers represent the mutated cyclization element (mutCYC). The primer H shares identical sequences with pSY-1 plasmid in the vicinity of Bsu36I site
(underlined). The two products, PCR1 and PCR2, produced using the
primer sets E/F and G/H were purified, mixed, and used for a third PCR
in the presence of the primer set E/H. This final PCR product was purified and used for in vitro transcription to generate
5'-TR/mutCYC RNA.
To construct a PCR fragment containing the
3'-UTR373nt/mutCYC that contains mutations within the
cyclization sequence complementary to that in 5'-TR/mutCYC), a
PCR-based mutagenesis protocol was followed. PCR1 was obtained using
the 5'-primer (A), the 3'-primer (I),
5'-CAGCGCTCTCTCTGTGTTTTTTGTTTTGGGGGGG-3'. PCR2 was produced using 5' primer (J),
5'-AAACACAGAGAGAGCGCTGGGAAAGACCAGAGAT-3' and the 3'-primer
(B). The underlined complementary sequences in I and J primers
represent mutated cyclization element (mutCYC). p190-24 plasmid was
used as the template for PCR. The two products, PCR1 and PCR2, produced
using the primer sets A/I and J/B were purified, mixed, and used for a
third PCR in the presence of the primer set A/B. This final PCR product
was purified and used for in vitro transcription to generate
the 3'-UTR/mutCYC RNA.
Preparation of RNA Templates
The RNA templates used in the in vitro RdRP assays
are shown in Fig. 1. To synthesize RNA templates containing 3'-terminal 373 nt (3'-UTR373nt) or the subgenomic RNA templates, the
plasmid constructs, p190.24 (56) and pSY-2, respectively, were
linearized with XbaI. The supercoiled plasmids were used as
templates for PCR. The PCR products or the XbaI-linearized
plasmids were used in the in vitro transcription reaction
catalyzed by either SP6 (for the 3'-UTR373nt RNA) or T7 RNA
polymerase (for subgenomic RNAs) using conditions supplied by the
manufacturer (Promega). Briefly, the in vitro transcription
reactions were carried out at 37 °C for 3 h in reaction
mixtures (100 µl) containing the 1× buffer (40 mM
Tris-HCl, pH 7.5, 6 mM MgCl2, 2 mM
spermidine, 10 mM NaCl), 5 µg of the DNA templates, a
mixture of four rNTPs (0.5 mM each), 100 units of RNasin,
10 mM dithiothreitol, and 5 units of T7 or SP6 RNA
polymerase. Then the reaction mixtures were digested with 5 units of
RNase-free DNase I (Promega) at 37 °C for 20 min to remove the DNA
templates. The RNA transcripts were extracted with phenol at pH 4.5 and
precipitated with ethanol. The quality of RNA products was analyzed
electrophoretically and quantified spectrophotometically. Because of
the 26 nt from the vector sequence at the 5'-end, the
3'-UTR373nt RNA is actually 399 nt in length but is
referred to in this study as 3'-UTR373nt. Nonviral
exogenous RNAs were prepared by linearizing three different vector
plasmids (pSP64, pSP70, and pTM1) with six different restriction enzymes. RNAs were prepared by in vitro transcription and
purified as described above.
In Vitro RdRP Assay
The in vitro RdRP assay was performed in 50-µl
reaction mixtures containing 50 mM Hepes, pH 7.3, 3 mM magnesium acetate, 6 µM zinc acetate, 25 mM potassium acetate, 60 units of RNase inhibitor, 10 mM -mercaptoethanol, 0.5 mM each ATP, GTP,
and UTP, and 10 µM of CTP mixed with 10 µCi of
[ -32P]CTP (800 Ci/mmol), 0.1 mg/ml actinomycin D, 10 µg of cytoplasmic extract from infected cells, and 5 µg of an
exogenous RNA template. As a control, a parallel reaction mixture
containing all the components except the cytoplasmic extract from the
uninfected C6/36 cell lysate (10 µg) was included. Controls in which
cytoplasmic extracts from infected or uninfected cells but without any
exogenous RNA were also included. Reaction mixtures were incubated at
30 °C for 1.5 h. To carry out the kinetics of RdRP reaction,
seven separate RdRP reactions that included DEN2-infected cytoplasmic
extracts and the subgenomic RNA template were initiated. At time
intervals of 0, 5, 10, 15, 20, 30, and 40 min, reactions were
terminated by the addition of EDTA (10 mM). The samples
were extracted with phenol, pH 4.5, and precipitated by the addition of
0.1 volume of 3 M sodium acetate, pH 5.2, and 2.5 volumes
of 100% ethanol in the presence of 5 µg of yeast tRNA (Ambion). The
RNA products were analyzed using either polyacrylamide, 7 M
urea or by formaldehyde-agarose gel electrophoresis, followed by autoradiography.
Analysis of RdRP Products by RNase A Digestion
The RdRP products separated on PAGE, 7 M urea gels
were cut out and eluted in 400 µl of elution buffer (2 M
ammonium acetate, 1% SDS, 1 mM EDTA, and 25 µg/ml tRNA)
either at 37 °C for overnight or at 65 °C for 4 h. After
briefly spinning down gel slices, the supernatants were precipitated
overnight with 1 ml of 100% ethanol at 20 °C. The eluted products
were treated with or without RNase A (Sigma; 5 ng/µl) in 20 µl of
either 2× SSC (300 mM NaCl and 30 mM sodium
citrate, pH 7.2) or 0.1× SSC (15 mM NaCl and 1.5 mM sodium citrate, pH 7.2) at 37 °C for 30 min. The
reactions were stopped by adding 30 µl of TES stop buffer (10 mM Tris-HCl, pH 8.0, 50 mM EDTA, and 0.2%
SDS), followed by phenol extraction and ethanol precipitation in the
presence of 5 µg of yeast tRNA. The RNase A-treated samples were
analyzed on formaldehyde agarose gel, followed by autoradiography.
Sodium Periodate Oxidation of RNA
In vitro transcribed RNAs were dissolved in 200 µl
of 50 mM NaOAc, pH 5.0. 50 µl of 0.1 M
NaIO4 (20 mM) was added and then incubated for
1 h at room temperature. Lysine (60 mM) was added to
saturate the excess periodate and further incubated for 3 h at
room temperature. The reactions were phenol extracted and precipitated with ethanol. The pellets were washed with 70% EtOH and dissolved in
water and subsequently desalted with Bio-Gel P gel column (Bio-Rad). The periodate-treated RNAs were quantified spectrophotometrically and
visualized on PAGE, 7 M urea gel by acridine orange.
 |
RESULTS |
Cytoplasmic Extracts from DEN2-infected Mosquito (C6/36) Cells Are
Active in the Synthesis of RNA from the Exogenous
Templates--
Previous studies showed that flavivirus RdRP activity
was tightly associated with intracellular membranes in the cytoplasmic fractions of flavivirus-infected mammalian (monkey kidney cell line
(Vero), or baby hamster kidney cell line (BHK-21)) cells (37-40, 62,
63). The earlier studies examined the incorporation of labeled
nucleotides into the three RNA species that were synthesized from
endogenous viral RNA templates. We sought to develop an in vitro RdRP assay that could utilize exogenous RNA templates that contain either 3'- or 5'-untranslated regions or both to determine the
sequence requirements for RNA synthesis and to characterize the
proteins that interact with these elements. We chose to use an
established Aedes albopictus (C6/36) cell line for
preparation of cytoplasmic extracts from DEN2-infected cells (see
"Experimental Procedures") because the viral titers are
significantly higher in C6/36 cells than in vertebrate cells (64).
We constructed cDNA clones containing the putative regulatory
regions of the viral genome at the 5'-TR and 3'-UTR under the control
of either the T7 or SP6 promoter as described under "Experimental Procedures." pSY-2 contains the subgenomic cDNA (720 nt)
corresponding to both 5'-TR230nt and 3'-UTR (full-length)
of the genome linked together in the same molecule. The
5'-TR230nt/wtCYC plasmid contains the cDNA
corresponding to the 5'-terminal region (230 nt) of the genome; both
cDNAs were downstream of the T7 promoter. The
3'-UTR373nt/wt CYC plasmid contains the SP6 promoter along
with 26 nt from the vector followed by the 3'-UTR373nt.
Plasmids containing mutations in the 5'-CYC or 3'-CYC motif
within either the 5'-TR230nt or the
3'-UTR373nt were constructed as described under
"Experimental Procedures" (Fig.
1).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Plasmid constructs used for the synthesis of
RNA templates. Details regarding the construction of these plasmid
constructs are given under "Experimental Procedures." The 5'- and
3'-UTR are depicted as filled, and open horizontal
rectangular boxes, respectively. T7 or SP6 promoters are shown as
indicated. Wild type and mutant complementary cyclization sequences are
shown as closed and shaded vertical boxes,
respectively.
|
|
First, we analyzed whether our cytoplasmic extracts contained the
putative viral replicase components, NS3 and NS5, by Western blot
analysis using rabbit polyclonal anti-NS3 and -NS5. Both NS3 and NS5
proteins were readily detected in the cytoplasmic extracts prepared
from DEN2-infected cells but not from the uninfected cells (Fig.
2).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 2.
Detection of NS3 and NS5 in cytoplasmic
extracts from infected C6/36 cells. C6/36 cells were infected with
dengue virus type 2 (DEN2) and at 36 h post-infection, cytoplasmic
extracts were prepared as described under "Experimental
Procedures." The extracts were fractionated by SDS-PAGE and analyzed
by Western blot using polyclonal antibodies against NS3 and NS5 and a
chemiluminescence detection system. M, control uninfected
cell lysate; D, DEN2-infected cell lysate.
|
|
For the in vitro RdRP assay, exogenous RNAs were synthesized
as run-off transcripts in the in vitro transcription
reactions on either XbaI-linearized plasmids or the PCR DNAs
as described under "Experimental Procedures." The
3'-UTR373nt RNA synthesized from the
XbaI-linearized plasmid contains 4 additional nucleotides complementary to the 5' overhang (5'-CTAG-3') extending the authentic 3'-end of viral RNA (referred as 3'-UTR373+4nt
RNA-XbaI). However, the RNA synthesized by the SP6 RNA
polymerase on the PCR template would lack this 3' extension of 4 nt
(3'-UTR373nt RNA-PCR) and maintain the authentic 3'-end of
viral genome. Both 3'-UTR RNAs include the highly conserved cyclization
motif located from nucleotide positions 90 to 100 from the 3'-end
(3'-wtCYC). The subgenomic RNA containing both 5'-TR and full-length
3'-UTR was synthesized as a run off transcript by T7 RNA polymerase
either from the XbaI-linearized pSY-2plasmid (720 + 4 nt) or
the PCR product (720 nt). The subgenomic RNA includes the wild type
cyclization motifs, which are complementary to each other (Fig. 1).
The RdRP reactions were carried out using the 3'-UTR373+4nt
RNA or the 3'-UTR373nt RNA as the exogenous RNA template and cytoplasmic lysates from either the DEN2-infected or uninfected cells (Fig. 3A, lanes
2 and 3). Control RdRP assays lacking the exogenous RNA
template were also included (Fig. 3A, lanes 4 and 5). The labeled RdRP products were analyzed on partially
denaturing 4% polyacrylamide gels containing 7 M urea
(PAGE, 7 M urea). The results of the in vitro
RdRP assay shown in Fig. 3 indicate that both uninfected and
DEN2-infected cell lysates gave rise to a labeled product of the same
size as the input 3'-UTR373+4nt RNA (Fig. 3A,
lanes 2 and 3, respectively, and also Fig.
3B, lane 1). However, DEN2-infected cell lysates
produced a distinctly labeled product that migrated faster than the
size expected for the input 3'-UTR373+4nt RNA (Fig. 3,
A, lane 2, and B, lane 1).
In contrast, the RdRP assays carried out in the absence of an exogenous
RNA template but in the presence of cytoplasmic extracts from infected
or uninfected cells did not produce either of the products, indicating
that these two products were formed only when the exogenous RNA
template was added (Fig. 3A, compare lanes 4 and
5 with lanes 2 and 3). Analysis of six
nonviral RNA templates generated from vector plasmids as controls
indicated that only two produced faster migrating RNA species like the
3'-UTR373+4nt RNA (data not shown). The labeled products
with mobilities slower than the input exogenous RNA were also formed
with cytoplasmic extracts from DEN2-infected cells (Fig. 3A,
lanes 2 and 4). These are likely to be the
products formed by the viral replicase utilizing the endogenous viral
RNA templates as reported previously (37). However, these products did
not fractionate into distinct species observed previously (37),
probably because the gel system we used is selected to fractionate
products formed from the small exogenous RNA templates.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 3.
Analysis of RNA products formed in
vitro. Exogenous RNA templates (5 µg) were
synthesized from either XbaI-linearized plasmids or
PCR-generated DNA. The RdRP assays were carried out with either DEN-2
infected (D) or uninfected (M) cell lysates for
1.5 h at 30 °C as described under "Experimental
Procedures." The products were fractionated by PAGE (4%) containing
7 M urea and analyzed by autoradiography. 1×
denotes the labeled RNA product which is of the same size as the input
template RNA. 2× denotes the RNA product with a faster
mobility in this gel system. Later experiments showed that this RNA has
a double-stranded hairpin-like structure with a size twice the size of
input RNA. A, exogenous 3'-UTR373nt RNA produced
from the XbaI-linearized plasmid which would contain 4 additional nucleotides complementary to the XbaI overhang
was used. Lane 1, labeled 3UTR373+4nt RNA as a
marker; lanes 2 and 3, exogenous
3'-UTR373+4nt RNA added; lanes 4 and
5, no exogenous RNA added. B, the exogenous
3'-UTR373nt RNA (lanes 1-4) or the subgenomic
RNA (lanes 5-8) was synthesized from either
XbaI-linearized plasmids (marked as XbaI in
lanes 1, 3, 5, and 7) or
from the PCR-generated DNAs (marked as PCR in lanes
2, 4, 6, and 8).
|
|
However, the 3'-UTR373nt RNA template generated from the
PCR product did not produce the faster migrating species in the RdRP assay with DEN2-infected extracts (Fig. 3B, lane
2). The faster migrating species were also not formed when
uninfected cell lysates were used with either of the 3'-UTR RNA
templates (Fig. 3A, lane 3, and B,
lanes 3 and 4). In contrast, the subgenomic RNA
template, which contained the 4 additional nucleotides complementary to the XbaI-5' overhang or generated from the PCR DNA lacking
these 4 nt at its 3' end, formed the faster migrating species (marked as 2×) as well as the unit-sized RNA product (marked as
1×). The faster migrating RNA product was observed in the
RdRP reaction that contained only the DEN2-infected cell lysates (Fig.
3B, lanes 5 and 6). These experiments
have been repeated six times with consistent results.
Because both DEN2-infected and uninfected cell lysates produced RNA
products of unit size (1×) with the exogenous RNA templates, it is
possible that this RNA was the product of 3'-terminal labeling by the
host-encoded terminal nucleotidyl transferase in both cases. A second
possibility is that de novo initiation by the DEN2-infected lysate at the 3'-end of template strand produced the ( )-strand RNA,
which could migrate as 1× in the partially denaturing gel electrophoresis system. On the other hand, the faster migrating RNA
could be either a prematurely terminated ( )-strand product or an RNA
that is highly compact in structure, such as a double-stranded RNA hairpin.
To characterize the labeled RNA products of the RdRP assays further,
the faster migrating product formed with 3'-UTR373+4nt RNA
template was eluted from the PAGE, 7 M urea gel and
digested by RNase A under conditions of high ionic strength (see
"Experimental Procedures"). The products of RNase A digestion were
analyzed by electrophoresis on a formaldehyde-agarose gel (Fig.
4A). Under conditions of high
ionic strength, the double-stranded regions in RNA are resistant to
RNase A, whereas single-stranded regions are susceptible. The results
showed that the faster migrating RNA product of
3'-UTR373+4nt RNA template had twice the size of the input
RNA template (2×) prior to RNase A digestion (Fig. 4A,
lane 3) but migrated as a unit-sized RNA (1×) after RNase A
digestion under conditions of high ionic strength (Fig. 4A, lane 4). These results indicated that the faster migrating
product is a double-stranded hairpin that had a single-stranded region susceptible to RNase A. The RNA size markers and an aliquot of the RdRP
reaction mixture were loaded in lanes 1 and 2 of
Fig. 4A, respectively. The faster migrating RNA products
formed from the subgenomic RNA templates (generated from the PCR DNA
and XbaI-linearized plasmid) also had twice the size (2×)
of input RNAs before RNase A digestion (Fig. 4B, lanes
3 and 7) but migrated as a unit-sized (1×) product
after RNase A digestion (lanes 4 and 8).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 4.
Analysis of RNA products formed in
vitro by RNase A digestion. The faster migrating
(2×) and the input template-sized RNA (1×)
products shown in Fig. 3 were eluted from the PAGE/urea gel and
digested with RNase A under high salt conditions. The digested products
and the controls were analyzed by formaldehyde-agarose gel as described
under "Experimental Procedures." A, lane 1,
RNA markers; lane 2, the products formed in the in
vitro assay; lanes 3 and 4, eluted 2×
product before and after RNase A digestion, respectively. To detect the
low amounts of radioactivity in lanes 3 and 4,
the same autoradiogram was developed by longer exposure. A composite
picture is shown. B, an in vitro assay was
performed with subgenomic RNA (720 nt) synthesized from either
XbaI-linearized or PCR-generated DNA, and the RNA products
were analyzed by RNase A digestion under high salt conditions.
1× and 2× are as defined in Fig. 3.
|
|
Next, we sought to analyze the 1× product, which was formed in
reactions containing lysates from either uninfected or DEN2-infected C6/36 cells. The in vitro assays using uninfected cell
lysates with the 3'-UTR373nt and the subgenomic RNA
templates did not produce appreciable 1× labeled product. The 1×
labeled RNA products formed from the 3'-UTR373+4nt and the
subgenomic RNAs as templates with DEN2-infected cell lysates were
isolated from the PAGE/urea gel and digested with RNase A. The results
showed that the 1× products formed with the subgenomic RNA templates
synthesized from XbaI-linearized plasmid and the PCR DNA
were resistant to RNase A under conditions of high ionic strength (Fig.
4B, lanes 2 and 6). This result
suggested that the 1× product contained the input template RNA and the
complementary ( )-strand RNA synthesized in the RdRP reaction, which
would anneal when isolated from the gel and become resistant to RNase
A. These results did not distinguish between the possibilities that the
1× product was formed by de novo initiation of RNA
synthesis at the 3'-end of the template or arising from the digestion
of the 2× hairpin product by a nuclease (see below). However, the 1×
product formed with the 3'-UTR373+4nt RNA template and
uninfected cell lysate (Fig. 3A, lane 3) was sensitive to RNase A under these conditions, suggesting that it is a
single-stranded RNA (data not shown). This RNA product is likely to be
formed by the action of the host terminal nucleotidyl transferase,
which has been observed in earlier studies as a membrane-associated enzyme (38, 65, 66).
Kinetics of the Formation of RNA Products in the RdRP
Assays--
To determine the pathway for the formation of the
double-stranded (2×) hairpin product and whether the unit-sized RNA
was formed independent of the hairpin product, a time course of RdRP reaction was performed. The standard RdRP reactions were initiated and
at the end of each indicated time point, EDTA was added (10 mM) to terminate the reaction. The RNA products formed at
various time points were analyzed by formaldehyde-agarose gel
electrophoresis prior to or after digestion with RNase A (Fig.
5). The results shown in Fig.
5A indicate that in 10 min of incubation time, the 1×
product was formed first at detectable levels that increased gradually
with time. In contrast, the 2× product was formed with a lag of 15 min, and the levels increased significantly over the time course of
incubation. In addition, there were other RNA products formed starting
at 10 min whose mobilities were between those of 1× and 2× products.
In comparison, the results obtained after RNase A digestion of these
time course samples (Fig. 5B) indicated that the 1× product
formed at 10 min of incubation was predominantly sensitive to RNase A,
suggesting that this RNA species is likely to be the product of a
terminal nucleotidyl transferase. However, the 2× product formed
between 15 and 40 min, upon digestion with RNase A, was converted
predominantly to RNase A-resistant 1× product. The RNA species of
intermediate mobilities were essentially sensitive to RNase A, which
yielded two small RNA fragments as seen first with the 10-min sample.
These results revealed a pathway for the formation of the
double-stranded hairpin product as follows. The RNA template is
initially modified by the 3'-end elongation to an RNase A-sensitive
product by either terminal nucleotidyl transferase or the viral
replicase or both. This first intermediate is further elongated to a
second intermediate (with a mobility between 1× and 2×), which is
predominantly a RNase A-sensitive product but contains some
double-stranded region to yield small RNase A-resistant products (Fig.
5B, 10 min lane). Further incubation of the reaction between
15 and 40 min results in a RNA product having a hairpin (2×)
structure. This RNA product has a predominantly RNase A-resistant, double-stranded region and a limited single-stranded loop region sensitive to RNase A. These results suggest that a small amount of the
RNase A-resistant 1× product, formed in a 90-min standard RdRP
reaction with the subgenomic RNA template (Fig. 4B),
originated from the double-stranded hairpin (2×) product during the
course of incubation.

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 5.
Kinetics of RdRP activity with the exogenous
subgenomic RNA template. A, seven RdRP reactions were
initiated using DEN2-infected cell lysates and exogenous subgenomic RNA
template as described under "Experimental Procedures." Each of the
reactions was terminated by the addition of EDTA (10 mM).
RNA products were purified by phenol extraction and ethanol
precipitation. One-half of each sample was digested with RNase A. The
untreated (A) and RNase A-treated (B) samples
were analyzed by electrophoresis on two separate formaldehyde-agarose
gels, followed by autoradiography. The first lane indicates
the labeled marker subgenomic RNA (720 nt).
|
|
5'-terminal Region of DEN2-RNA Is Required for Self-primed RNA
Synthesis at the 3'-End--
Our results presented in Figs. 3 and 4
suggested that self-priming at the 3'-end of the RNA template by viral
RdRP activity to produce a hairpin-like structure was dependent on the
nature of the RNA template used. The 3'-UTR373+4nt RNA was
active, whereas the 3'-UTR373nt generated from the PCR
fragment was essentially inactive. This result was independently
confirmed by removal of the XbaI 5' overhang from the
linearized plasmid by digestion with S1 nuclease at two different
concentrations (3 and 10 units/5 µg). Sequence analysis at the 3'-end
of the S1 nuclease-treated plasmids indicated that at 3 units of
enzyme/5 µg of plasmid DNA, the 3'-UTR373nt cDNA end
corresponded to the authentic 3' terminus, whereas at 10 units of the
enzyme/5 µg of DNA, it had lost three additional nucleotides from the
3' terminus. The 3'-UTR373nt RNA templates produced from
the S1 nuclease-treated plasmids by the SP6 RNA polymerase-catalyzed
in vitro transcription were also inactive like the RNA
produced from the PCR product (data not shown). On the other hand, the
subgenomic RNAs generated from either the S1 nuclease-treated plasmids
under identical conditions used for the 3'-UTR373+4nt
plasmid or from the PCR fragment (which would correspond to the
authentic 3' terminus) were active in the RdRP assays in producing the
hairpin-like products (data not shown).
These results indicated that the subgenomic RNA is intrinsically active
in the RdRP reaction to produce the self-primed product, whereas the
3'-UTR373nt RNA is not. The data suggested that the 5'-terminal sequences of DEN2 RNA are likely to play a role in modulating the structure at the 3'-end to confer a self-priming activity to the subgenomic RNA in the RdRP assay. To address this hypothesis, we tested whether the addition of 5'-terminal RNA containing 230 nt (5'-TR230nt) would confer the
self-priming activity to the 3'-UTR373nt RNA in our RdRP
assay. The RdRP assay was carried out using the 3'-UTR373nt
RNA alone or in the presence of 5'-TR230nt RNA as
templates. The results shown in Fig. 6
indicated that the 3'-UTR373nt RNA alone was inactive as a
template in the RdRP assay (lane 2), confirming the previous
observations; however, the 5'-TR230nt added in
trans could activate the 3'-UTR373nt RNA to have
the self-primed RNA synthesis activity in the RdRP reaction to produce the faster migrating 2× product (lane 3). Moreover, the
5'-TR230nt RNA by itself had self-priming activity
(lane 4). The faster migrating products were confirmed to be
2× by running the samples in formaldehyde-agarose gels (data not shown
and Fig. 7).

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 6.
5'-TR230nt RNA mediates RNA
synthesis at the 3'-end of the inactive 3'-UTR373nt RNA
template. The in vitro replication assay was carried
out using exogenously added RNA templates synthesized from the
XbaI-linearized plasmid (3'-UTR373+4nt RNA;
lane 1), the PCR-generated DNA (3'-UTR373nt RNA;
lane 2), 5'-terminal 230-nt RNA (5'-TR230nt RNA;
lane 4), or a mixture of 3'-UTR373nt and
5'-TR230nt RNAs (lane 3). RNA products formed
were fractionated by PAGE (5.5%), 7 M urea gel system and
analyzed by autoradiography. The input template-sized and dimer-sized
RNA products formed from the 3'-UTR373nt or the
5'-TR230nt RNAs are indicated.
|
|

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 7.
Role of cyclization motifs in RNA synthesis
mediated by the 5'-TR230nt RNA at the 3'-end of
3'-UTR373nt RNA template. The 9-nt cyclization motifs
(CYC) were mutated either individually to disrupt or together to
restore complementarity. The mutant plasmids were used for in
vitro transcription to synthesize 5'-TR230nt and
3'-UTR373nt RNAs containing either wild type or mutant CYC
motifs (wtCYC or mutCYC). RNAs were used in the
in vitro assays, and the products were analyzed by
formaldehyde-agarose gel system. Lane 1,
3'-UTR373nt+4nt RNA; lane 2,
3'-UTR373nt RNA with wtCYC; lane 3,
3'-UTR373nt RNA with mutCYC; lane 4,
3'-UTR373nt RNA + 5'-TR230nt RNA containing
wtCYC motifs; lane 5, 3'-UTR373nt RNA with
mutCYC + 5'-TR230nt RNA with wtCYC motifs; lane
6, 5'-TR230nt RNA with wtCYC motif alone; lane
7, 3'-UTR373nt RNA with wtCYC motif + 5'-TR230nt RNA with mutCYC motif; lane 8, both
3'-UTR373nt RNA and 5'-TR230nt RNA with
complementary mutCYC motifs; lane 9, 5'-TR230nt
RNA with mutCYC motif alone. In this gel system, the labeled input
template-sized (1×) 3'-UTR373nt RNA, which has an
additional 26 nt from the vector sequences, appears to have migrated
close to the 2× of 5'-TR230nt RNA product.
|
|
The conserved sequence elements within the 5'- and 3'-terminal regions
of flavivirus RNA genomes (5'-CS1, 3'-CS1, 3'-CS2, and RCS2) include
the complementary motifs, "cyclization sequences" (5'-CYC and
3'-CYC; Fig. 1) (58). The role of 5'- and 3'-CYC motifs or the other
conserved sequence elements in the viral life cycle is unknown at
present. The results shown thus far indicated that the
3'-UTR373nt RNA, which includes the 3'-CYC element, is inactive in the RdRP assay; however, the presence of the 5'-terminal region containing the entire 5'-UTR (96 nt) with conserved stem-loop structure (57) and the 5'-CS1 element along with the 3'-UTR in the same
molecule (for example, in the subgenomic RNA) or its addition in
trans to the 3'-UTR RNA activated RNA synthesis at the
3'-end of the 3'-UTR RNA.
These results raised the interesting question of whether the
cyclization motifs play any role in conferring the template activity of
3'-UTR373nt RNA in the RdRP assay. To address this
question, a mutant cDNA containing point mutations in the 5'-CYC
motif that was designed to disrupt base pairing with the 3'-CYC motif
was constructed (5'-TR/mutCYC; Fig. 1). A second construct containing complementary mutations in the 3'-CYC motif within the
3'-UTR373nt cDNA (3'-UTR373nt/mutCYC) was
also made. These mutant cDNAs were used to generate the
5'-TR230nt/mutCYC and 3'-UTR373nt/mutCYC RNAs,
which were then used as templates in the RdRP assays. The results shown
in Fig. 7 indicate that the wild type or mutant 3'-UTR373nt
RNA was inactive in the self-priming activity (lanes 2 and
3; lane 1 contained the control,
3'-UTR373+4nt RNA, that has this activity). However, the
addition of 5'-TR230nt RNA containing the wild type 5'-CYC
element activated the 3'-UTR373nt RNA containing the wild
type 3'-CYC element (lane 4) but not the mutant 3'-CYC
element (lane 5). Similarly, the mutant
5'-TR230nt/mutCYC RNA could not transactivate the wild type
3'-UTR373nt RNA (lane 7), whereas it could
transactivate the mutant 3'-UTR373nt/mutCYC RNA (lane
8). We also observed that both mutant and wild type 5'-TR230nt RNAs were active by themselves in the RdRP assay
(lanes 6 and 9). This template activity was
probably due to a specific structure of these RNAs recognized by the
RdRP.
These results taken together indicated that the 5'- and 3'-terminal
regions of the viral genome do functionally interact with each other.
This interaction is required for the template activity of
3'-UTR373nt RNA in self-primed RNA synthesis by a copy-back mechanism at the 3'-end of viral RNA catalyzed by the viral-specific RdRP. In addition, the CYC motifs, which are complementary to each
other, are important in modulating this interaction.
The Role of 3'-OH Moieties of 3'-UTR/wtCYC and 5'-TR/wtCYC RNAs in
Self-primed RNA Synthesis in Vitro--
We sought to determine whether
the 3'-OH group of the 5'-TR/wtCYC RNA was required for activation of
the template activity of the 3'-UTR/wtCYC RNA in the self-primed RNA
synthesis. The 3'-OH group of each of the RNA template was oxidized by
sodium periodate followed by treatment with lysine to remove the excess periodate. The RNAs were purified and used in the RdRP assays. The
results shown in Fig. 8 indicate that the
5'-TR/wtCYC and 3'-UTR/wtCYC RNAs, when present together, are active in
self-primed RNA synthesis from the 3'-OH moiety of each template
molecule (Fig. 8, A, lane 2, and B,
lane 5). When the 3'-UTR/wtCYC RNA was treated with
periodate, its self-priming activity was nearly abolished in the
presence of the untreated 5'-TR/wtCYC RNA, whereas the untreated
5'-TR/wtCYC RNA by itself was still active to produce the 1× and 2×
products (Fig. 8, A, lane 3, and B,
lane 7). Similarly, when the 5'-TR/wtCYC RNA was treated
with periodate, its self-priming activity was nearly abolished, but its
ability to activate the 3'-UTR/wtCYC RNA in trans for
self-primed RNA synthesis was still intact (Fig. 8, A and
B, lanes 4 and 6, respectively). When
both RNA templates were treated with periodate, the self-priming
activity was severely reduced (Fig. 8, A and B,
lanes 5 and 8, respectively). Similar results
were observed by treatment of the subgenomic RNA with sodium periodate
(Fig. 8A, lanes 7 and 8). These
results suggested that the self-priming RNA synthesis at the
3'-OH end of the RNA templates is very specific and is not modified by
the cell extracts during the in vitro RdRP reactions. In
addition, the trans activation of 3'-UTR/wtCYC RNA by
5'-TR/wtCYC RNA for RNA synthesis does not require the 3'-OH
group of the latter. These results are also consistent with the
conclusion derived from the results of Fig. 5 because the formation of
both 1× and 2× products were abolished by blocking the 3'-OH group of
the subgenomic RNA (Fig. 8A, lanes 7 and
8).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 8.
3'-hydroxyl group of the subgenomic RNA or
the 3'-UTR373nt RNA is required for RNA synthesis mediated
by the 5'-TR230nt sequences. RNAs were synthesized by
in vitro transcription and treated with sodium periodate
(indicated as ) followed by lysine to block the 3'-OH group.
Purified RNAs were used in the in vitro RdRP assays as
described under "Experimental Procedures." Lane 1 in
A and lane 9 in B refer to the
periodate-untreated 3'-UTR373nt+4nt RNA as control. RNAs 3'
and 5' refer to 3'-UTR373nt RNA and 5'-TR230nt
RNA, respectively. A, analysis of products was carried out
by PAGE/urea system. B, analysis of products by
formaldehyde-agarose gel system. The products were detected by
autoradiography.
|
|
 |
DISCUSSION |
In this study, we describe the first flaviviral replicase assay
system that utilizes cytoplasmic extracts from dengue virus-infected mosquito (C6/36) cells and exogenously added subgenomic RNA templates to study the mechanism of viral replication in vitro. The
RNA templates used in this in vitro system contain the
conserved sequence (CS) elements found near or within the 5'- and
3'-UTR of many flavivirus RNA genomes examined to date (Ref. 58 and for
a review see Ref. 8). These sequences also include those that are
predicted to form potential stem-loop (5'- and 3'-SL) structures
(56-58, 67, 68). Biochemical evidence for the formation of SL
structures was provided by enzymatic RNA structure probing studies (56, 68) and from the sequence data of some rare cDNA clones derived from three flaviviral RNAs, which could only be explained by
self-primed cDNA synthesis by reverse transcriptase at the 3'-end
of these viral RNAs (58).
Our results shown in this study indicate that the self-primed RNA
synthesis producing a hairpin-like structure (2×) occurs in the viral
replicase-catalyzed reaction, which appears to be the major species
formed in vitro. A minor product formed in a RdRP assay
carried out using either infected or uninfected cell extracts has the
same mobility as the input RNA in a partially denaturing gel
electrophoresis system. However, analysis of the product formed with
uninfected cell lysates indicated that it was sensitive to RNase A
digestion, whereas the product formed with infected cell lysates was
RNase-resistant, suggesting that the latter product was double-stranded
RNA. These results suggested that the RNase A-sensitive product formed
in the reaction containing the uninfected cell lysates is likely to be
formed by the host terminal nucleotidyl transferase by addition of
nucleotides to the 3'-end of the RNA template.
The kinetics of the RdRP reaction catalyzed by the viral replicase
reveals that the initial RNA product formed is also sensitive to RNase
A, suggesting that it was the product of limited 3'-end elongation by
either the host terminal nucleotidyl transferase or by the viral
replicase or both. This RNA intermediate is then converted to the
hairpin-like product by a copy-back mechanism. The results of sodium
periodate treatment that abrogated the formation of both 1× and 2×
products are also consistent with this conclusion. The RNase
A-resistant 1× product observed in a 90-min RdRP reaction could arise
from digestion of the single-stranded region of the 2× product by
nuclease(s) during the RdRP reaction. However, formation of this
product at least in part by de novo synthesis by the viral replicase at the 3'-end of RNA template could not be ruled out.
The role of the conserved sequence elements 3'-CS1, 3'-CS2, 3'-RCS2,
and 5'-CS1 in flaviviral life cycle is unknown. The 9-nt complementary
sequence elements, known as cyclization sequences (3'-CYC and 5'-CYC),
are thought to cyclize viral RNA to form a panhandle structure with
11-12 contiguous base pairs that include the adjacent sequences (58).
The 3'-UTR373nt RNA, as well as the subgenomic RNA used in
this study, include these conserved sequence elements. Whether these
CYC elements in flaviviral RNAs are involved in formation of cyclic
intermediates during replication or in some other event in the viral
life cycle is yet to be determined. The free energy of cyclization was
calculated to be 9 to 11 kcal at 25 °C, supporting the
possibility that cyclization could indeed occur (58). We analyzed the
potential secondary structure within the 3'-UTR and predicted base
pairing between 5'- and 3'-CYC motifs in the 0.7-kilobase subgenomic
RNA using the MFOLD program (69) (data not shown). The predicted
structure for the 3'-SL alone up to CS1 showed that the 3'-CYC motif is
in a loop region, whereas the predicted structure for the subgenomic
RNA showed the 5'- and 3'-CYC motifs form base pairings in a stable
stem containing 11 base pairs (from 134 to 144 nt from the 3'-end). Studies using RNA structure probing methods are essential to determine the secondary structure of the subgenomic template RNA active in our
in vitro assay. Interestingly, Alphaviral and Bunyaviral RNAs have been reported to cyclize under physiological conditions (70,
71). It was proposed that the cyclization event would fulfill a
putative requirement for binding of viral RNA replicase to both 5'- and
3'-terminal regions prior to initiation of viral replication (58).
The results of our study suggest that interactions between the 5'-and
3'-terminal regions, mediated by conserved CYC motifs, result in a
conformational change that is a prerequisite for self-primed RNA
synthesis at the 3'-end of the 3'-UTR by the viral replicase. Cellular
proteins that are shown to bind the 3'-stem-loop structure of a
flavivirus RNA (48, 49, 72) could play an important role in modulating
the stability of this interaction. Although the complementarity between
the CYC motifs might be the driving force in bringing the ends of the
genome together, it is possible that there are additional interactions,
mediated by other conserved motifs such as 3'-CS2 and RCS2, which could
play a role in conferring a specific conformation for initiation of RNA synthesis.
In a recent report, a functional interaction in vivo between
two RNA components, RNA-1 and RNA-2 of the plant virus, red clover necrotic mosaic virus genome, was demonstrated (73). In that study, a
34-nt segment of RNA-2 component was shown to be required for
subgenomic RNA synthesis from genomic RNA-1 component in
vivo. Interestingly, within the RNA-1 and RNA-2 components, two
8-nt motifs complementary to each other were shown to be important for
subgenomic RNA synthesis. Again, mutations that maintained complementarity were active, suggesting that base pairing interactions between the two motifs are likely to be involved in subgenomic RNA
synthesis (73).
Complete replication of RNA genomes of the positive strand viruses,
cucumber mosaic virus, tobacco mosaic virus, and nodavirus by either a
partially purified or by a crude membrane-bound replicase complex have
been reported (28, 34, 74). In other in vitro template-dependent replication systems, only synthesis of
the negative strand to form the double-stranded RNA intermediate has been demonstrated (35). In some in vitro RdRP reactions, the template RNA gave rise to not only the complementary ( )-strand RNA
but also RNA species larger than the input RNA templates. For example,
poliovirus RdRP gave rise to dimer-sized RNA products in
vivo and in vitro (75-78). The evidence suggested that
the 3'-ends were generated by endonucleolytic attack of the 3'-SL
structure(s) of polioviral RNA, which then served as templates for the
RdRP giving rise to a variety of self-primed products. Moreover,
blocking the 3'-OH by sodium periodate did not have any effect on the
generation of dimer-sized products, because new 3'-OH was presumably
generated by the endonucleolytic cleavage (77). However, the RNA
synthesis at the 3'-end of the RNA templates used in our system appears to be specific to RNA structure. In contrast, purified preparations of
viral RdRP of poliovirus (79), hepatitis C virus (80) or dengue virus
(81) can utilize exogenous viral or synthetic RNA templates for RNA
synthesis in vitro but without any template specificity or
structure dependence.
A few other viral RdRP such as cucumber mosaic virus (28), brome mosaic
virus (31, 82), and turnip crinkle virus (32) showed template and
structure-specific RNA synthesis. The turnip crinkle virus RdRP
utilized the ( )-strand of satellite C RNA as a template and produced
two non-template-sized products, a panhandle-like structure and a
hairpin-like structure (L- and S-RNAs, respectively) by terminal
elongation of the 3'-end. The formation of the L-RNA had specific
sequence and structural requirements, whereas the S-RNA was formed from
all ( )-strand RNAs tested (50). These RdRP preparations had some
cellular proteins that perhaps contributed to the template specificity
(for a review see Ref. 36). Cellular proteins from the DEN2-infected
extracts are also likely to contribute to the exogenous template
specificity observed in this study.
Other studies have shown that cis-acting signals required
for viral RNA replication are noncontiguous in the viral genome of the
brome mosaic virus (44, 83, 84), tobacco mosaic virus (85), and the
double-stranded RNA virus of yeast (L-A virus) (Ref. 41 and for a
review see Ref. 36). Moreover, in the single-stranded negative sense
RNA genome of the Rhabdoviridae family (the vesicular stomatitis virus
RNA (86)) and in the segmented influenza virus RNA genome (87),
interactions between 5'- and 3'-terminal sequences involve
self-complementary sequences. The mechanisms of viral replication and
the specificity of interactions of the viral replicases and viral RNA
genomes are likely to be distinct in these different viruses.
Development of an in vitro RdRP assay for a flavivirus that
can utilize exogenous RNA templates and identification of a functional
interaction between conserved sequence elements within the 5'- and
3'-terminal regions that play a role in viral RNA synthesis in
vitro are important steps toward unraveling the mechanism of
flavivirus replication.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant AI-32078.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7421. Tel.: 913-588-7018; Fax:
913-588-7440; E-mail: rpadmana@kumc.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
RdRP, RNA-dependent RNA polymerase(s);
UTR, untranslated region;
nt, nucleotide(s);
TR, terminal region(s);
PAGE, polyacrylamide gel
electrophoresis;
PCR, polymerase chain reaction;
CS, conserved
sequence;
SL, stem-loop;
wt, wild type.
 |
REFERENCES |
| 1.
|
Monath, T. P.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
2395-2400[Abstract/Free Full Text]
|
| 2.
|
Kautner, I.,
Robinson, M. J.,
and Kuhnle, U.
(1997)
J. Pediatr.
131,
516-524[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Gubler, D. J.,
and Clark, G. G.
(1995)
Emerg. Infect. Dis.
1,
55-57[Medline]
[Order article via Infotrieve]
|
| 4.
|
Irie, K.,
Mohan, P. M.,
Sasaguri, Y.,
Putnak, R.,
and Padmanabhan, R.
(1989)
Gene (Amst.)
75,
197-211[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Svitkin, Y. V.,
Lyapustin, V. N.,
Lashkevich, V. A.,
and Agol, V. I.
(1984)
Virology
135,
536-541[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Markoff, L.
(1989)
J. Virol.
63,
3345-3352[Abstract/Free Full Text]
|
| 7.
|
Nowak, T.,
Farber, P. M.,
Wengler, G.,
and Wengler, G.
(1989)
Virology
169,
365-376[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Chambers, T. J.,
Hahn, C. S.,
Galler, R.,
and Rice, C. M.
(1990)
Annu. Rev. Microbiol.
44,
649-688[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Bazan, J. F.,
and Fletterick, R. J.
(1989)
Virology
171,
637-639[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Gorbalenya, A. E.,
Donchenko, A. P.,
Koonin, E. V.,
and Blinov, V. M.
(1989)
Nucleic Acids Res.
17,
3889-3897[Abstract/Free Full Text]
|
| 11.
|
Chambers, T. J.,
Weir, R. C.,
Grakoui, A.,
McCourt, D. W.,
Bazan, J. F.,
Fletterick, R. J.,
and Rice, C. M.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
8898-8902[Abstract/Free Full Text]
|
| 12.
|
Preugschat, F.,
Yao, C. W.,
and Strauss, J. H.
(1990)
J. Virol.
64,
4364-4374[Abstract/Free Full Text]
|
| 13.
|
Falgout, B.,
Pethel, M.,
Zhang, Y. M.,
and Lai, C. J.
(1991)
J. Virol.
65,
2467-2475[Abstract/Free Full Text]
|
| 14.
|
Chambers, T. J.,
Grakoui, A.,
and Rice, C. M.
(1991)
J. Virol.
65,
6042-6050[Abstract/Free Full Text]
|
| 15.
|
Wengler, G.,
Czaya, G.,
Farber, P. M.,
and Hegemann, J. H.
(1991)
J. Gen. Virol.
72,
851-858[Abstract/Free Full Text]
|
| 16.
|
Zhang, L.,
Mohan, P. M.,
and Padmanabhan, R.
(1992)
J. Virol.
66,
7549-7554[Abstract/Free Full Text]
|
| 17.
|
Cahour, A.,
Falgout, B.,
and Lai, C.-J.
(1992)
J. Virol.
66,
1535-1542[Abstract/Free Full Text]
|
| 18.
|
Clum, S.,
Ebner, K. E.,
and Padmanabhan, R.
(1997)
J. Biol. Chem.
272,
30715-30723[Abstract/Free Full Text]
|
| 19.
|
Murthy, H. M.,
Clum, S.,
and Padmanabhan, R.
(1999)
J. Biol. Chem.
274,
5573-5580[Abstract/Free Full Text]
|
| 20.
|
Gorbalenya, A. E.,
Koonin, E. V.,
Donchenko, A. P.,
and Blinov, V. M.
(1989)
Nucleic Acids Res.
17,
4713-4730[Abstract/Free Full Text]
|
| 21.
|
Koonin, E. V.
(1992)
Trends Biochem. Sci.
17,
495-497[Medline]
[Order article via Infotrieve]
|
| 22.
|
Kadare, G.,
and Haenni, A. L.
(1997)
J. Virol.
71,
2583-2590[Medline]
[Order article via Infotrieve]
|
| 23.
|
Li, H.,
Clum, S.,
You, S.,
Ebner, K. E.,
and Padmanabhan, R.
(1999)
J. Virol.
73,
3108-3116[Abstract/Free Full Text]
|
| 24.
|
Westaway, E. G.
(1987)
Adv. Virus Res.
33,
45-90[Medline]
[Order article via Infotrieve]
|
| 25.
|
Poch, O.,
Sauvaget, I.,
Delarue, M.,
and Tordo, N.
(1989)
EMBO J.
8,
3867-3874[Medline]
[Order article via Infotrieve]
|
| 26.
|
O'Reilly, E. K.,
and Kao, C. C.
(1998)
Virology
252,
287-303[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Blumenthal, T.,
and Carmichael, G. G.
(1979)
Annu. Rev. Biochem.
48,
525-548[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Hayes, R. J.,
and Buck, K. W.
(1990)
Cell
63,
363-368[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Wu, S. X.,
and Kaesberg, P.
(1991)
Virology
183,
392-396[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Molla, A.,
Paul, A. V.,
and Wimmer, E.
(1991)
Science
254,
1647-1651[Abstract/Free Full Text]
|
| 31.
|
Quadt, R.,
Kao, C. C.,
Browning, K. S.,
Hershberger, R. P.,
and Ahlquist, P.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
1498-1502[Abstract/Free Full Text]
|
| 32.
|
Song, C.,
and Simon, A. E.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8792-8796[Abstract/Free Full Text]
|
| 33.
|
Barton, D. J.,
Black, E. P.,
and Flanegan, J. B.
(1995)
J. Virol.
69,
5516-5527[Abstract]
|
| 34.
|
Osman, T. A.,
and Buck, K. W.
(1996)
J. Virol.
70,
6227-6234[Abstract]
|
| 35.
|
Lemm, J. A.,
Bergqvist, A.,
Read, C. M.,
and Rice, C. M.
(1998)
J. Virol.
72,
6546-6553[Abstract/Free Full Text]
|
| 36.
|
Lai, M. M.
(1998)
Virology
244,
1-12[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Chu, P. W.,
and Westaway, E. G.
(1985)
Virology
140,
68-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Grun, J. B.,
and Brinton, M. A.
(1986)
J. Virol.
60,
1113-1124[Abstract/Free Full Text]
|
| 39.
|
Chu, P. W.,
and Westaway, E. G.
(1987)
Virology
157,
330-337[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Bartholomeusz, A. I.,
and Wright, P. J.
(1993)
Arch. Virol.
128,
111-121[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Esteban, R.,
Fujimura, T.,
and Wickner, R. B.
(1989)
EMBO J.
8,
947-954[Medline]
[Order article via Infotrieve]
|
| 42.
|
Nakhasi, H. L.,
Cao, X. Q.,
Rouault, T. A.,
and Liu, T. Y.
(1991)
J. Virol.
65,
5961-5967[Abstract/Free Full Text]
|
| 43.
|
Pardigon, N.,
and Strauss, J. H.
(1992)
J. Virol.
66,
1007-1015[Abstract/Free Full Text]
|
| 44.
|
Pogue, G. P.,
and Hall, T. C.
(1992)
J. Virol.
66,
674-684[Abstract/Free Full Text]
|
| 45.
|
Rohll, J. B.,
Percy, N.,
Ley, R.,
Evans, D. J.,
Almond, J. W.,
and Barclay, W. S.
(1994)
J. Virol.
68,
4384-4391[Abstract/Free Full Text]
|
| 46.
|
Rohll, J. B.,
Moon, D. H.,
Evans, D. J.,
and Almond, J. W.
(1995)
J. Virol.
69,
7835-7844[Abstract]
|
| 47.
|
Carpenter, C. D.,
Oh, J. W.,
Zhang, C.,
and Simon, A. E.
(1995)
J. Mol. Biol.
245,
608-622[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Blackwell, J. L.,
and Brinton, M. A.
(1995)
J. Virol.
69,
5650-5658[Abstract]
|
| 49.
|
Shi, P. Y.,
Li, W.,
and Brinton, M. A.
(1996)
J. Virol.
70,
6278-6287[Abstract]
|
| 50.
|
Song, C.,
and Simon, A. E.
(1995)
J. Mol. Biol.
254,
6-14[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Hsue, B.,
and Masters, P. S.
(1997)
J. Virol.
71,
7567-7578[Abstract]
|
| 52.
|
Hsue, B.,
and Masters, P. S.
(1998)
Adv. Exp. Med. Biol.
440,
297-302[Medline]
[Order article via Infotrieve]
|
| 53.
|
Schuppli, D.,
Miranda, G.,
Qiu, S.,
and Weber, H.
(1998)
J. Mol. Biol.
283,
585-593[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Stewart, S. R.,
and Semler, B. L.
(1998)
Nucleic Acids Res.
26,
5318-5326[Abstract/Free Full Text]
|
| 55.
|
Zeng, L.,
Falgout, B.,
and Markoff, L.
(1998)
J. Virol.
72,
7510-7522[Abstract/Free Full Text]
|
| 56.
|
Mohan, P. M.,
and Padmanabhan, R.
(1991)
Gene (Amst.)
108,
185-191[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Brinton, M. A.,
and Dispoto, J. H.
(1988)
Virology
162,
290-299[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Hahn, C. S.,
Hahn, Y. S.,
Rice, C. M.,
Lee, E.,
Dalgarno, L.,
Strauss, E. G.,
and Strauss, J. H.
(1987)
J. Mol. Biol.
198,
33-41[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Yaegashi, T.,
Vakharia, V. N.,
Page, K.,
Sasaguri, Y.,
Feighny, R.,
and Padmanabhan, R.
(1986)
Gene (Amst.)
46,
257-267[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Smith, T. J.,
Brandt, W. E.,
Swanson, J. L.,
McCown, J. M.,
and Buescher, E. L.
(1970)
J. Virol.
5,
524-532[Abstract/Free Full Text]
|
| 61.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 62.
|
Grun, J. B.,
and Brinton, M. A.
(1987)
J. Virol.
61,
3641-364[Abstract/Free Full Text]
|
| 63.
|
Grun, J. B.,
and Brinton, M. A.
(1988)
J. Gen. Virol.
69,
3121-3127[Abstract/Free Full Text]
|
| 64.
|
Mussgay, M.,
Enzmann, P. J.,
Horzinek, M. C.,
and Weiland, E.
(1975)
Prog. Med. Virol.
19,
257-323[Medline]
[Order article via Infotrieve]
|
| 65.
|
Dasgupta, A.,
Zabel, P.,
and Baltimore, D.
(1980)
Cell
19,
423-429[CrossRef][Medline]
[Order article via Infotrieve]
|
| 66.
|
Andrews, N. C.,
Levin, D.,
and Baltimore, D.
(1985)
J. Biol. Chem.
260,
7628-7635[Abstract/Free Full Text]
|
| 67.
|
Rice, C. M.,
Lenches, E. M.,
Eddy, S. R.,
Shin, S. J.,
Sheets, R. L.,
and Strauss, J. H.
(1985)
Science
229,
726-733[Abstract/Free Full Text]
|
| 68.
|
Brinton, M. A.,
Fernandez, A. V.,
and Dispoto, J. H.
(1986)
Virology
153,
113-121[CrossRef][Medline]
[Order article via Infotrieve]
|
| 69.
|
Zuker, M.,
Jaeger, J. A.,
and Turner, D. H.
(1991)
Nucleic Acids Res.
19,
2707-2714[Abstract/Free Full Text]
|
| 70.
|
Hsu, M. T.,
Kung, H. J.,
and Davidson, N.
(1974)
Cold Spring Harbor Symp. Quant. Biol.
38,
943-50[Abstract/Free Full Text]
|
| 71.
|
Hewlett, M. J.,
Pettersson, R. F.,
and Baltimore, D.
(1977)
J. Virol.
21,
1085-1093[Abstract/Free Full Text]
|
| 72.
|
Blackwell, J. L.,
and Brinton, M. A.
(1997)
J. Virol.
71,
6433-6444[Abstract]
|
| 73.
|
Sit, T. L.,
Vaewhongs, A. A.,
and Lommel, S. A.
(1998)
Science
281,
829-832[Abstract/Free Full Text]
|
| 74.
|
Wu, S. X.,
Ahlquist, P.,
and Kaesberg, P.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
11136-11140[Abstract/Free Full Text]
|
| 75.
|
Young, D. C.,
Tuschall, D. M.,
and Flanegan, J. B.
(1985)
J. Virol.
54,
256-264[Abstract/Free Full Text]
|
| 76.
|
Lubinski, J. M.,
Kaplan, G.,
Racaniello, V. R.,
and Dasgupta, A.
(1986)
J. Virol.
58,
459-467[Abstract/Free Full Text]
|
| 77.
|
Hey, T. D.,
Richards, O. C.,
and Ehrenfeld, E.
(1987)
J. Virol.
61,
802-811[Abstract/Free Full Text]
|
| 78.
|
Richards, O. C.,
Hey, T. D.,
and Ehrenfeld, E.
(1987)
J. Virol.
61,
2307-2310[Abstract/Free Full Text]
|
| 79.
|
Neufeld, K. L.,
Richards, O. C.,
and Ehrenfeld, E.
(1991)
J. Biol. Chem.
266,
24212-24219[Abstract/Free Full Text]
|
| 80.
|
Behrens, S. E.,
Tomei, L.,
and De Francesco, R.
(1996)
EMBO J.
15,
12-22[Medline]
[Order article via Infotrieve]
|
| 81.
|
Tan, B. H.,
Fu, J.,
Sugrue, R. J.,
Yap, E. H.,
Chan, Y. C.,
and Tan, Y. H.
(1996)
Virology
216,
317-325[CrossRef][Medline]
[Order article via Infotrieve]
|
| 82.
|
Siegel, R. W.,
Adkins, S.,
and Kao, C. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11238-11243[Abstract/Free Full Text]
|
| 83.
|
Lahser, F. C.,
Marsh, L. E.,
and Hall, T. C.
(1993)
J. Virol.
67,
3295-3303[Abstract/Free Full Text]
|
| 84.
|
Quadt, R.,
Ishikawa, M.,
Janda, M.,
and Ahlquist, P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4892-4896[Abstract/Free Full Text]
|
| 85.
|
Leathers, V.,
Tanguay, R.,
Kobayashi, M.,
and Gallie, D. R.
(1993)
Mol. Cell. Biol.
13,
5331-5347[Abstract/Free Full Text]
|
| 86.
|
Wertz, G. W.,
Whelan, S.,
LeGrone, A.,
and Ball, L. A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8587-8591[Abstract/Free Full Text]
|
| 87.
|
Luo, G. X.,
Luytjes, W.,
Enami, M.,
and Palese, P.
(1991)
J. Virol.
65,
2861-2867[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Vashist, M. Anantpadma, H. Sharma, and S. Vrati
La protein binds the predicted loop structures in the 3' non-coding region of Japanese encephalitis virus genome: role in virus replication
J. Gen. Virol.,
June 1, 2009;
90(6):
1343 - 1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Polacek, P. Friebe, and E. Harris
Poly(A)-binding protein binds to the non-polyadenylated 3' untranslated region of dengue virus and modulates translation efficiency
J. Gen. Virol.,
March 1, 2009;
90(3):
687 - 692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Lodeiro, C. V. Filomatori, and A. V. Gamarnik
Structural and Functional Studies of the Promoter Element for Dengue Virus RNA Replication
J. Virol.,
January 15, 2009;
83(2):
993 - 1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Polacek, J. E. Foley, and E. Harris
Conformational Changes in the Solution Structure of the Dengue Virus 5' End in the Presence and Absence of the 3' Untranslated Region
J. Virol.,
January 15, 2009;
83(2):
1161 - 1166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Teramoto, Y. Kohno, P. Mattoo, L. Markoff, B. Falgout, and R. Padmanabhan
Genome 3'-end repair in dengue virus type 2
RNA,
December 1, 2008;
14(12):
2645 - 2656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-H. Song, S.-I. Yun, Y.-J. Choi, J.-M. Kim, C.-H. Lee, and Y.-M. Lee
A complex RNA motif defined by three discontinuous 5-nucleotide-long strands is essential for Flavivirus RNA replication
RNA,
September 1, 2008;
14(9):
1791 - 1813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Zhang, H. Dong, Y. Zhou, and P.-Y. Shi
Genetic Interactions among the West Nile Virus Methyltransferase, the RNA-Dependent RNA Polymerase, and the 5' Stem-Loop of Genomic RNA
J. Virol.,
July 15, 2008;
82(14):
7047 - 7058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Mori, T. Yamashita, Y. Tanaka, Y. Tsuda, T. Abe, K. Moriishi, and Y. Matsuura
Processing of Capsid Protein by Cathepsin L Plays a Crucial Role in Replication of Japanese Encephalitis Virus in Neural and Macrophage Cells
J. Virol.,
August 15, 2007;
81(16):
8477 - 8487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Deas, C. J. Bennett, S. A. Jones, M. Tilgner, P. Ren, M. J. Behr, D. A. Stein, P. L. Iversen, L. D. Kramer, K. A. Bernard, et al.
In Vitro Resistance Selection and In Vivo Efficacy of Morpholino Oligomers against West Nile Virus
Antimicrob. Agents Chemother.,
July 1, 2007;
51(7):
2470 - 2482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Clyde, J. L. Kyle, and E. Harris
Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis
J. Virol.,
December 1, 2006;
80(23):
11418 - 11431.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Gritsun and E. A. Gould
Direct repeats in the 3' untranslated regions of mosquito-borne flaviviruses: possible implications for virus transmission.
J. Gen. Virol.,
November 1, 2006;
87(Pt 11):
3297 - 3305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Takhampunya, R. Padmanabhan, and S. Ubol
Antiviral action of nitric oxide on dengue virus type 2 replication.
J. Gen. Virol.,
October 1, 2006;
87(Pt 10):
3003 - 3011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Rakotondrafara, C. Polacek, E. Harris, and W. A. Miller
Oscillating kissing stem-loop interactions mediate 5' scanning-dependent translation by a viral 3'-cap-independent translation element
RNA,
October 1, 2006;
12(10):
1893 - 1906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Filomatori, M. F. Lodeiro, D. E. Alvarez, M. M. Samsa, L. Pietrasanta, and A. V. Gamarnik
A 5' RNA element promotes dengue virus RNA synthesis on a circular genome
Genes & Dev.,
August 15, 2006;
20(16):
2238 - 2249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Takhampunya, S. Ubol, H.-S. Houng, C. E. Cameron, and R. Padmanabhan
Inhibition of dengue virus replication by mycophenolic acid and ribavirin
J. Gen. Virol.,
July 1, 2006;
87(7):
1947 - 1952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Kofler, V. M. Hoenninger, C. Thurner, and C. W. Mandl
Functional Analysis of the Tick-Borne Encephalitis Virus Cyclization Elements Indicates Major Differences between Mosquito-Borne and Tick-Borne Flaviviruses.
J. Virol.,
April 1, 2006;
80(8):
4099 - 4113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Clyde and E. Harris
RNA Secondary Structure in the Coding Region of Dengue Virus Type 2 Directs Translation Start Codon Selection and Is Required for Viral Replication
J. Virol.,
March 1, 2006;
80(5):
2170 - 2182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Thivierge, V. Nicaise, P. J. Dufresne, S. Cotton, J.-F. Laliberte, O. Le Gall, and M. G. Fortin
Plant Virus RNAs. Coordinated Recruitment of Conserved Host Functions by (+) ssRNA Viruses during Early Infection Events
Plant Physiology,
August 1, 2005;
138(4):
1822 - 1827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Yon, T. Teramoto, N. Mueller, J. Phelan, V. K. Ganesh, K. H. M. Murthy, and R. Padmanabhan
Modulation of the Nucleoside Triphosphatase/RNA Helicase and 5'-RNA Triphosphatase Activities of Dengue Virus Type 2 Nonstructural Protein 3 (NS3) by Interaction with NS5, the RNA-dependent RNA Polymerase
J. Biol. Chem.,
July 22, 2005;
280(29):
27412 - 27419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-W. Chiu, R. M. Kinney, and T. W. Dreher
Control of Translation by the 5'- and 3'-Terminal Regions of the Dengue Virus Genome
J. Virol.,
July 1, 2005;
79(13):
8303 - 8315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Alvarez, M. F. Lodeiro, S. J. Luduena, L. I. Pietrasanta, and A. V. Gamarnik
Long-Range RNA-RNA Interactions Circularize the Dengue Virus Genome
J. Virol.,
June 1, 2005;
79(11):
6631 - 6643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Deas, I. Binduga-Gajewska, M. Tilgner, P. Ren, D. A. Stein, H. M. Moulton, P. L. Iversen, E. B. Kauffman, L. D. Kramer, and P.-Y. Shi
Inhibition of Flavivirus Infections by Antisense Oligomers Specifically Suppressing Viral Translation and RNA Replication
J. Virol.,
April 15, 2005;
79(8):
4599 - 4609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Hardy and C. M. Rice
Requirements at the 3' End of the Sindbis Virus Genome for Efficient Synthesis of Minus-Strand RNA
J. Virol.,
April 15, 2005;
79(8):
4630 - 4639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Kinney, C. Y.-H. Huang, B. C. Rose, A. D. Kroeker, T. W. Dreher, P. L. Iversen, and D. A. Stein
Inhibition of Dengue Virus Serotypes 1 to 4 in Vero Cell Cultures with Morpholino Oligomers
J. Virol.,
April 15, 2005;
79(8):
5116 - 5128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sharma, B. J. O'Donnell, and J. B. Flanegan
3'-Terminal Sequence in Poliovirus Negative-Strand Templates Is the Primary cis-Acting Element Required for VPgpUpU-Primed Positive-Strand Initiation
J. Virol.,
March 15, 2005;
79(6):
3565 - 3577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tilgner and P.-Y. Shi
Structure and Function of the 3' Terminal Six Nucleotides of the West Nile Virus Genome in Viral Replication
J. Virol.,
August 1, 2004;
78(15):
8159 - 8171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Panaviene, T. Panavas, S. Serva, and P. D. Nagy
Purification of the Cucumber Necrosis Virus Replicase from Yeast Cells: Role of Coexpressed Viral RNA in Stimulation of Replicase Activity
J. Virol.,
August 1, 2004;
78(15):
8254 - 8263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. van Dijk, E. V. Makeyev, and D. H. Bamford
Initiation of viral RNA-dependent RNA polymerization
J. Gen. Virol.,
May 1, 2004;
85(5):
1077 - 1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Thurner, C. Witwer, I. L. Hofacker, and P. F. Stadler
Conserved RNA secondary structures in Flaviviridae genomes
J. Gen. Virol.,
May 1, 2004;
85(5):
1113 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nomaguchi, T. Teramoto, L. Yu, L. Markoff, and R. Padmanabhan
Requirements for West Nile Virus (-)- and (+)-Strand Subgenomic RNA Synthesis in Vitro by the Viral RNA-dependent RNA Polymerase Expressed in Escherichia coli
J. Biol. Chem.,
March 26, 2004;
279(13):
12141 - 12151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. You, D. D. Stump, A. D. Branch, and C. M. Rice
A cis-Acting Replication Element in the Sequence Encoding the NS5B RNA-Dependent RNA Polymerase Is Required for Hepatitis C Virus RNA Replication
J. Virol.,
February 1, 2004;
78(3):
1352 - 1366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Lo, M. Tilgner, and P.-Y. Shi
Potential High-Throughput Assay for Screening Inhibitors of West Nile Virus Replication
J. Virol.,
December 1, 2003;
77(23):
12901 - 12906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Vlot and J. F. Bol
The 5' Untranslated Region of Alfalfa Mosaic Virus RNA 1 Is Involved in Negative-Strand RNA Synthesis
J. Virol.,
October 15, 2003;
77(20):
11284 - 11289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Lo, M. Tilgner, K. A. Bernard, and P.-Y. Shi
Functional Analysis of Mosquito-Borne Flavivirus Conserved Sequence Elements within 3' Untranslated Region of West Nile Virus by Use of a Reporting Replicon That Differentiates between Viral Translation and RNA Replication
J. Virol.,
September 15, 2003;
77(18):
10004 - 10014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nomaguchi, M. Ackermann, C. Yon, S. You, and R. Padmanbhan
De Novo Synthesis of Negative-Strand RNA by Dengue Virus RNA-Dependent RNA Polymerase In Vitro: Nucleotide, Primer, and Template Parameters
J. Virol.,
August 15, 2003;
77(16):
8831 - 8842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. Sun, J. A. Lemm, D. R. O'Boyle II, J. Racela, R. Colonno, and M. Gao
Specific Inhibition of Bovine Viral Diarrhea Virus Replicase
J. Virol.,
June 15, 2003;
77(12):
6753 - 6760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-I. Yun, S.-Y. Kim, C. M. Rice, and Y.-M. Lee
Development and Application of a Reverse Genetics System for Japanese Encephalitis Virus
J. Virol.,
June 1, 2003;
77(11):
6450 - 6465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Cologna and R. Rico-Hesse
American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells
J. Virol.,
April 1, 2003;
77(7):
3929 - 3938.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. E. Yocupicio-Monroy, F. Medina, J. Reyes-del Valle, and R. M. del Angel
Cellular Proteins from Human Monocytes Bind to Dengue 4 Virus Minus-Strand 3' Untranslated Region RNA
J. Virol.,
March 1, 2003;
77(5):
3067 - 3076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Hardy, J. Marcotrigiano, K. J. Blight, J. E. Majors, and C. M. Rice
Hepatitis C Virus RNA Synthesis in a Cell-Free System Isolated from Replicon-Containing Hepatoma Cells
J. Virol.,
February 1, 2003;
77(3):
2029 - 2037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. H. Lai, S. Dempsey, J. Y. N. Lau, Z. Hong, and W. Zhong
In Vitro RNA Replication Directed by Replicase Complexes Isolated from the Subgenomic Replicon Cells of Hepatitis C Virus
J. Virol.,
February 1, 2003;
77(3):
2295 - 2300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ali, K. D. Tardif, and A. Siddiqui
Cell-Free Replication of the Hepatitis C Virus Subgenomic Replicon
J. Virol.,
October 25, 2002;
76(23):
12001 - 12007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Y. Shi, M. Tilgner, M. K. Lo, K. A. Kent, and K. A. Bernard
Infectious cDNA Clone of the Epidemic West Nile Virus from New York City
J. Virol.,
May 13, 2002;
76(12):
5847 - 5856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ackermann and R. Padmanabhan
De Novo Synthesis of RNA by the Dengue Virus RNA-dependent RNA Polymerase Exhibits Temperature Dependence at the Initiation but Not Elongation Phase
J. Biol. Chem.,
October 19, 2001;
276(43):
39926 - 39937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Khromykh, H. Meka, K. J. Guyatt, and E. G. Westaway
Essential Role of Cyclization Sequences in Flavivirus RNA Replication
J. Virol.,
July 15, 2001;
75(14):
6719 - 6728.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Hayasaka, L. Ivanov, G. N. Leonova, A. Goto, K. Yoshii, T. Mizutani, H. Kariwa, and I. Takashima
Distribution and characterization of tick-borne encephalitis viruses from Siberia and far-eastern Asia
J. Gen. Virol.,
June 1, 2001;
82(6):
1319 - 1328.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M.-J. Kim and C. Kao
Factors regulating template switch in vitro by viral RNA-dependent RNA polymerases: Implications for RNA-RNA recombination
PNAS,
April 12, 2001;
(2001)
81077198.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Ta and S. Vrati
Mov34 Protein from Mouse Brain Interacts with the 3' Noncoding Region of Japanese Encephalitis Virus
J. Virol.,
June 1, 2000;
74(11):
5108 - 5115.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. You, B. Falgout, L. Markoff, and R. Padmanabhan
In Vitro RNA Synthesis from Exogenous Dengue Viral RNA Templates Requires Long Range Interactions between 5'- and 3'-Terminal Regions That Influence RNA Structure
J. Biol. Chem.,
May 4, 2001;
276(19):
15581 - 15591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-J. Kim and C. Kao
Factors regulating template switch in vitro by viral RNA-dependent RNA polymerases: Implications for RNA-RNA recombination
PNAS,
April 24, 2001;
98(9):
4972 - 4977.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|